V02.00 Hib/MenC Risk Groups PGD amended to: 21/09/2018 include additional healthcare practitioners in Section 3 include statement on experimental storage data to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Elizabeth Graham Pharmacist 28/09/2018 Lead Pharmacist Immunisation – (Lead Author) and Countermeasures, PHE Shamez Ladhani 27/09/2018 Doctor Paediatric Infectious Disease Consultant, PHE Green Registered Nurse 26/09/2018 Nurse Consultant Immunisation – (Chair of Expert Panel) and Countermeasures, PHE This PGD has been peer reviewed by the PHE Immunisations PGD Expert Panel in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Ed Gardner Advanced Paramedic Practitioner/Emergency Care Practitioner, Medicines Manager, Proactive Care Lead Shamez Ladhani Paediatric Infectious Disease Consultant, Public Health England Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team Alison Mackenzie Consultant in Public Health Medicine / Screening and Immunisation Lead, Public Health England / NHS England (South West) Gill Marsh Senior Screening and Immunisation Manager, Public Health England / NHS England Lancashire and South Cumbria Lesley McFarlane Screening and Immunisation Co-ordinator, NHS England / Public Health England Leicestershire, Lincolnshire and Northamptonshire
V02.00 Hib/MenC Risk Groups PGD amended to: include additional healthcare practitioners in Section 3 include statement on experimental storage data to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates 21/09/2018 PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Pharmacist (Lead Author) Elizabeth Graham Lead Pharmacist – Immunisation and Countermeasures, PHE 28/09/2018 Doctor Shamez Ladhani Paediatric Infectious Disease Consultant, PHE 27/09/2018 Registered Nurse (Chair of Expert Panel) Green Nurse Consultant – Immunisation and Countermeasures, PHE 26/09/2018 This PGD has been peer reviewed by the PHE Immunisations PGD Expert Panel in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Ed Gardner Advanced Paramedic Practitioner/Emergency Care Practitioner, Medicines Manager, Proactive Care Lead Shamez Ladhani Paediatric Infectious Disease Consultant, Public Health England Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team Alison Mackenzie Consultant in Public Health Medicine / Screening and Immunisation Lead, Public Health England / NHS England (South West) Gill Marsh Senior Screening and Immunisation Manager, Public Health England / NHS England Lancashire and South Cumbria Lesley McFarlane Screening and Immunisation Co-ordinator, NHS England / Public Health England Leicestershire, Lincolnshire and Northamptonshire